Profile of confirmed and symptomatic cases of COVID-19 that progressed to recovery without hospitalization in a Northeastern brazilian municipality
DOI:
https://doi.org/10.33448/rsd-v11i7.30127Keywords:
COVID-19; Coronavirus; Health Profile; Signs and Symptoms; Comorbidity.Abstract
Objective: to describe the clinical-epidemiological profile of confirmed and symptomatic cases of COVID-19 in a municipality in the Brazilian Northeast, which in turn progressed to recovery without hospitalization. Method: an ecological study of secondary data analysis of the Ministry of Health's eSUS-VE and FormSUS of the Municipal Health Department of São Cristóvão, Sergipe, Brazil. We evaluated 1,098 symptomatic people with a positive report for COVID-19 between April and August 2020, who in turn progressed to recovery without hospitalization, either in infirmary beds and/or ICU. Results: the mean age of recovered cases without hospitalization was 38.6 years and the majority were female (59.1%). The most prevalent symptoms were headache (62.7%; n= 688), cough (60.7%; n= 666) and fever (53.4%; n= 586). More than half had up to three simultaneous symptoms (65.3%). Dyspnea was the least reported symptom (19.9%). Only 22.6% had comorbidities, the most common being arterial hypertension and diabetes. Conclusion: there was a predominance of young people and adults without comorbidities among mild cases of COVID-19 who progressed to recovery without hospitalization.
References
Alkhouli, M., Nanjundappa, A., Annie, F., Bates, M. C. & Bhatt, D. L. (2020). Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry. n Mayo Clin Proc, 95(8):1613-1620.
Beeching, N. J., Fletcher, T. E. & Fowler, R. (2020). COVID-19. BMJ Best Practice.
Brasil (2022). Painel de casos de Doença pelo Coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. https://covid.saude.gov.br/
Brasil (2020). Guia de Vigilância Epidemiológica: Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2019, de 05 de agosto de 2020. Ministério da Saúde.
Casas-Rojo, J. M. et al. (2020). Características clínicas de los pacientes hospitalizados con COVID-19 en Espana: resultados del Registro SEMI-COVID-19. Rev Clin Esp.
Chen, J. (2020). Distinct Clinical Characteristics and Risk Factors for Mortality in Female Inpatients With Coronavirus Disease 2019 (COVID-19): A Sex-stratified, Large-scale Cohort Study in Wuhan, China. Clinical Infectious Diseases, 1–8.
Contejean, A. et al. (2020). Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris. Clinical Infectious Diseases.
Grupo Epidemiológico do Mecanismo de Resposta de Emergência da Nova Pneumonia Por Coronavírus no Centro Chinês de Controle e Prevenção de Doenças (2020). Principais características epidemiológicas da Nova Pneumonia por Coronavírus. Chinese Journal of Epidemiology, 41.
Johns Hopkins University (2022). Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE). https://coronavirus.jhu.edu/map.html
Li, J. et al. (2020). Clinical characteristics of emergency surgery patients infected with coronavirus disease 2019 (COVID-19) pneumonia in Wuhan, China. Surgery, 168:398-403.
Martins-Filho, P. R., de Souza Araújo, A. A., Quintans-Júnior, L. J., & Santos, V. S. (2020). COVID-19 fatality rates related to social inequality in Northeast Brazil: a neighbourhood-level analysis. Journal of travel medicine, 27(7).
Martins-Filho, P. R., Tavares, C., & Santos, V. S. (2020). Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. European journal of internal medicine, 76, 97–99.
Mikami, T. et al (2020). Risk Factors for Mortality in Patients with COVID-19 in New York City. J Gen Intern Med.
Vena, A. et al. (2020). Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clinical Microbiology and Infection.
Walker, P. G. T. et al. (2020). Report 12 - The Global Impact of COVID-19 and Strategies for Mitigation and Suppression. WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London.
Weston, S. & Frieman, MB (2020). COVID19: knowns, unknowns, and questions. mSphere, 5:e00203-20.
Wei, Y. et al. (2020). Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a singlecenter descriptive study. BMC Infectious Diseases, 20:549.
Wit, E., Doremalen, N. V., Falzarano, D. & Munster, V. J. (2016). SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol, 14:523–534.
World Health Organization (2020). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). WHO.
World Health Organization (2020a). WHO Director-General’s opening remarks at the media briefing on COVID-19. WHO.
Zhang, B. et al. (2020). Clinical characteristics of 82 cases of death from COVID-19. PLoS ONE, 15(7): e0235458.
Zhan, T. et al. (2020). Retrospective analysis of clinical characteristics of 405 patients with COVID-19. Journal of International Medical Research, 48(8):1–10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 José Marcos de Jesus Santos; Fernanda Rodrigues de Santana Góes; Mayra de Oliveira Mendonça; Deise Carolina Anunciação Souza; Beatriz Costa da Silva; Mário Luiz Tavares Mendes; Ingrid Tatiane Santos; João Batista Cavalcante Filho; Marcos Antônio de Azevedo Santana; Paulo Ricardo Martins-Filho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
